Invention Grant
US07708995B2 Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus
失效
使用TNF-α抑制剂治疗由髓核介导的神经障碍
- Patent Title: Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus
- Patent Title (中): 使用TNF-α抑制剂治疗由髓核介导的神经障碍
-
Application No.: US11521093Application Date: 2006-09-14
-
Publication No.: US07708995B2Publication Date: 2010-05-04
- Inventor: Kjell Olmarker , Bjorn Rydevik
- Applicant: Kjell Olmarker , Bjorn Rydevik
- Applicant Address: SE Molndal
- Assignee: Sciaticon AB
- Current Assignee: Sciaticon AB
- Current Assignee Address: SE Molndal
- Agency: Fish & Richardson P.C.
- Priority: SE9803276 19980925; SE9803710 19981029
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; C07K16/28
Abstract:
The present invention relates to a method and a pharmaceutical composition for treatment of nerve disorders comprising administration of a therapeutically effective dosage of at least two substances selected from the group consisting of TNF inhibitors, IL-1 inhibitors, IL-6 inhibitors, IL-8 inhibitors, FAS inhibitors, FAS ligand inhibitors, and IFN-gamma inhibitors. Preferably, at least one of the substances is a TNF inhibitor.
Public/Granted literature
- US20070104711A1 Use of certain drugs for treating nerve root injury Public/Granted day:2007-05-10
Information query
